VioQuest Pharmaceuticals, Inc.
VOQP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 0.04 | -0.01 | -0.08 |
| FCF Yield | -151.69% | -31.35% | -26.37% | -30.28% |
| EV / EBITDA | -1.04 | -3.50 | -1.04 | -2.96 |
| Quality | ||||
| ROIC | -613.09% | 0.00% | 194.99% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 36.20% | 43.60% |
| Cash Conversion Ratio | 0.65 | 0.78 | 0.29 | 0.94 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | 78.49% | 255.22% |
| Free Cash Flow Growth | -9.27% | -48.86% | -5.18% | -121.04% |
| Safety | ||||
| Net Debt / EBITDA | -0.34 | 0.52 | 0.56 | 0.85 |
| Interest Coverage | 8.65 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 3.88 | 2.33 |
| Cash Conversion Cycle | 0.00 | 0.00 | 74.48 | 103.03 |